Mathers CD, Boerma T, Ma FD. Global and regional causes of death. Br Med Bull. 2009;92(1):7–32.
Cheng SY, Zhao YD, Li J, Chen XY, Wang RD, Zeng JW. Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology. 2014;47:126–35.
Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung. 2009;38(2):151–62.
Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC. A PGC1-a-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–8.
Huh JY, Mougios V, Kabasakalis A, Fatouros I, Siopi A, Douroudos II. Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol Metab. 2014;99(11):E2154–61.
Ferrer-Martínez A, Ruiz-Lozano P, Chien KR. Mouse PeP: a novel peroxisomal protein linked to myoblast differentiation and development. Dev Dyn. 2002;224:154–67.
Xin C, Liu J, Zhang J, Zhu D, Wang H, Xiong L. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway. Int J Obes. 2016;40(3):443.
Lee HJ, Lee JO, Kim N, Kim JK, Kim HI, Lee YW. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Mol Endocrinol. 2015;29(6):873–81.
Rodríguez-Carmona A, Fontán MP, Alvarellos SS. Serum levels of the adipomyokine irisin in patients with chronic kidney disease. Nefrología. 2016;36(5):496–502.
Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769–78.
Crujeiras AB, Zulet MA, Lopez-Legarrea P, de la Iglesia R, Pardo M, Carreira MC. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering programin obese patients. Metabolism. 2014;63:520–31.
Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100:96–101.
Zhang W, Chang L, Zhang C, Zhang R, Li Z, Chai B. Irisin: a myokine with locomotor activity. Neurosci Lett. 2015;595:7–11.
Brondani LA, Boelter G, Assmann TS, Leitao CB, Canani LH, Crispim D. Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men. Metabolism. 2015;64:952–7.
Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. J Mol Cell Cardiol. 2015;87:138–47.
Han F, Zhang S, Hou N, Wang D, Sun X. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. Am J Physiol Heart Circ Physiol. 2015;309:H1501–8.
Lu J, Xiang G, Liu M, Mei W, Xiang L, Dong J. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-null diabetic mice. Atherosclerosis. 2015;243:438–48.
Chen J, Huang Y, Gusdon AM, Qu S. Irisin: a new molecular marker and target in metabolic disorder. Lipids Health Dis. 2015;14(1):2.
Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 2007;62(11):1251–7.
Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007;32(2):151–9.
Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belen CA. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8:e60563.
Carvalho AF, Rocha DQ, McIntyre RS, Mesquita LM, Köhler CA, Hyphantis TN. Adipokines as emerging depression biomarkers: a systematic review and meta-analysis. J Psychiatr Res. 2014;59:28–37.
Wang S, Pan J. Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism. Biochem Biophys Res Commun. 2016;474(1):22–8.
Schuch FB, Vancampfort D, Richards J, et al. Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res. 2016;77:42–51.
Wrann CD. FNDC5/irisin—their role in the nervous system and as a mediator for beneficial effects of exercise on the brain. Brain Plasticity. 2015;1(1):55–61.
Wu H, Guo P, Jin Z, et al. Serum levels of irisin predict short-term outcomes in ischemic stroke. Cytokine. 2018; https://doi.org/10.1016/j.cyto.2018.02.017.
Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsanl WG, Biller J. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.
Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009;72:2104–10.
DATA D. Structured clinical interview for DSM-IV axis I disorders. Washington: American Psychiatric Press; 1997.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
Bonita RR. Modification of Rankin scale: recovery of motor function after stroke. Stroke. 1988;19:1497–500.
Nowrouzi-Kia B, Li AKC, Nguyen C, et al. Heart disease and occupational risk factors in the Canadian population: an exploratory study using the Canadian community health survey. Safety Health Work. 2017; https://doi.org/10.1016/j.shaw.2017.07.008.
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.
Preiss K, Brennan L, Clarke D. A systematic review of variables associated with the relationship between obesity and depression. Obes Rev. 2013;14(11):906–18.
Jang HB, Kim HJ, Kang JH, Park SI, Park KH, Lee HJ. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metabolism. 2017;73:100–8.
Robson MJ, Quinlan MA, Blakely RD. Immune system activation and depression: roles of serotonin in the central nervous system and periphery. ACS Chem Neurosci. 2017;8(5):932–42.
Gao H, Zhu H, Zhang Y, et al. Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: a preliminary report. Clinical & Investigative Medicine. 2008;31(6):351–6.
Li DJ, Li YH, Yuan HB, Qu LF, Wang P. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism. 2017;68:31–42.
Anastasilakis AD, Koulaxis D, Kefala N, Polyzos SA, Upadhyay J, Pagkalidou E. Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy. Metabolism. 2017;73:1–8.
Efe TH, Açar B, Ertem AG. Serum irisin level can predict the severity of coronary artery disease in patients with stable angina. Korean Circ J. 2017;47(1):44–9.
Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metab Clin Exp. 2012;61:1725–38.
Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899–907.
Hwang YC, Jeon WS, Park CY, Youn BS. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype. Cardiovasc Diabetol. 2016;15:9.
Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–41.
Alis R, Sanchis-Gomar F, Pareja-Galeano H, Hernández-Mijares A, Romagnoli M, Víctor VM. Association between irisin and homocysteine in euglycemic and diabetic subjects. Clin Biochem. 2014;47(18):333–5.
Cheng LS, Tu WJ, Shen Y, Zhang LJ, Ji K. Combination of high-sensitivity C-reactive protein and homocysteine predicts the post-stroke depression in patients with ischemic stroke. Mol Neurobiol. 2018;55(4):2952-8.
Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J. 2013;27:1981–9.
Lehto SM, Huotari A, Niskanen L, Tolmunen T, Koivumaa-Honkanen H, Honkalampi K. Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatr Scand. 2010;121(3):209–15.
Van Sloten TT, Schram MT, Adriaanse MC, Dekker JM, Nijpels G, Teerlink T. Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn study. Psychol Med. 2014;44(7):1403–16.
Fu J, Han Y, Wang J, Liu Y, Zheng S, Zhou L. Irisin lowers blood pressure by improvement of endothelial dysfunction via AMPK-Akt-eNOS-NO pathway in the spontaneously hypertensive rat. J Am Heart Assoc. 2016;5(11):e003433.
Della FP, Abelaira HM, Réus GZ, Ribeiro KF, Antunes AR, Scaini G. Tianeptine treatment induces antidepressive-like effects and alters BDNF and energy metabolism in the brain of rats. Behav Brain Res. 2012;233(2):526–35.
Balzer BWR, Duke SA, Hawke CI. The effects of estradiol on mood and behavior in human female adolescents: a systematic review. Eur J Pediatr. 2015;174(3):289–98.
Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, Brockmann B. Evidence against a beneficial effect of irisin in humans. PLoS One. 2013;8:e73680.
Sanchis-Gomar F, Perez-Quilis C. Irisinemia: a novel concept to coin in clinical medicine? Ann Nutr Metab. 2013;63(1–2):60–1.